Renal function dynamics following co‐administration of sacubitril/valsartan and empagliflozin in patients with heart failure and type 2 diabetes

AIMS: The aim of this study was to evaluate the safety profile in terms of changes in renal function after co‐treatment with sacubitril/valsartan and empagliflozin in patients with type 2 diabetes (T2D) and heart failure with reduced ejection fraction (HFrEF). METHODS AND RESULTS: This multicentre o...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:ESC Heart Fail
Autori principali: de la Espriella, Rafael, Bayés‐Genís, Antoni, Morillas, Herminio, Bravo, Rafael, Vidal, Verónica, Núñez, Eduardo, Santas, Enrique, Miñana, Gema, Sanchis, Juan, Fácila, Lorenzo, Torres, Francisco, Górriz, Jose Luis, Valle, Alfonso, Núñez, Julio
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley and Sons Inc. 2020
Soggetti:
Original Research Articles
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7754982/
https://ncbi.nlm.nih.gov/pubmed/32964683
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ehf2.12965
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi